
    
      To determine if elexacfator-tezacaftor-ivacaftor improves the signs and symptoms of
      CF-related sinus disease, before and after initiation of triple combination therapy, each
      subject will undergo sinus CT scan and complete questionnaires related to signs and symptoms
      of sinus disease.
    
  